Avamys Nasal Spray

Avamys is a leading pharmaceutical brand used for the treatment of allergic rhinitis symptoms. It contains fluticasone furoate, a corticosteroid that reduces inflammation in the nasal passages. The brand was originally developed and launched by GlaxoSmithKline (GSK), a global healthcare company headquartered in the United Kingdom.

Manufacturing of Avamys typically takes place at GSK's specialized pharmaceutical facilities, with significant production historically linked to sites in the UK and Europe to serve global markets. The brand remains under the ultimate ownership of GSK plc, one of the world's largest research-based pharmaceutical and healthcare companies. GSK continues to manage the global distribution and scientific development of the product, ensuring compliance with international medical standards.